Nrx Pharmaceuticals Inc (NRXP)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-03-31	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate
Revenues	-	-	-
Income/Loss From Continuing Operations Before Tax	30.20% -5.512	-7.897	-6.528
Income Tax Expense/Benefit	-	-	-
Income/Loss From Continuing Operations After Tax	30.20% -5.512	-7.897	-6.528
Net Income/Loss	30.20% -5.512	-7.897	-6.528
Preferred Stock Dividends And Other Adjustments	-	-	-
Attributable To Noncontrolling Interest	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-

RPRX

$45.68

3.69%

MRNA

$53.83

6.87%

ROIV

$29.72

0.68%

BNTX

$101.95

1.78%

INSM

$143.57

4.21%

ONC

$292.94

2.03%